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HVEM is a member of the TNF receptor superfamily that plays a role in the development of various
inﬂammatory diseases. In this study, we show that HVEM deﬁciency attenuates adipose tissue
inﬂammatory responses and glucose intolerance in diet-induced obesity. Feeding a high-fat diet
(HFD) to HVEM-deﬁcient mice elicited a reduction in the number of macrophages and T cells inﬁl-
trated into adipose tissue. Proinﬂammatory cytokine levels in the adipose tissue decreased in HFD-
fed HVEM-deﬁcient mice, while levels of the anti-inﬂammatory cytokine IL-10 increased. Moreover,
glucose intolerance and insulin sensitivity were markedly improved in the HFD-fed HVEM-deﬁcient
mice. These ﬁndings indicate that HVEM may be a useful target for combating obesity-induced
inﬂammatory responses and insulin resistance.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Inﬂammation, a hallmark of obesity, is closely associated with
the development of obesity-related complications such as type II
diabetes and atherosclerosis. Adipose tissue inﬂammatory compo-
nents such as immune cells (e.g., macrophages and T cells) and
cytokines/chemokines play a role in obesity-induced inﬂammatory
processes [1,2], and modulation of the inﬂammatory components
ameliorates not only the obesity-induced inﬂammatory responses
but also metabolic complications [3–5]. However, the precise
mechanisms and molecules underlying adipose immune cell cross-
talk in obesity-related inﬂammation remain to be elucidated.
HVEM/TNFRSF14 (herpes simplex virus glycoprotein D for her-
pes virus entry mediator) is a member of the TNF receptor super-
family (TNFRSF), and the membrane receptor for LIGHT/TNFSF14
(lymphotoxin-related inducible ligand that competes for glycopro-
tein D binding to herpes virus entry mediator on T cells) [6,7].
HVEM is widely and constitutively expressed in various human
and rodent tissues, and strongly expressed on resting/activated im-
mune cells (e.g., T cells, B cells, and monocytes) and non-immune
cells (e.g., endothelial cells and adipocytes) [6,8,9]. The interactionchemical Societies. Published by E
Food Science and Nutrition,
749, South Korea. Fax: +82 52between HVEM and its ligand is involved in various inﬂammatory
processes, and thus is implicated in the development of a number
of inﬂammatory diseases (e.g., inﬂammatory bowel disease, rheu-
matoid arthritis, and nephritis) [8,10]. Blockade of HVEM/LIGHT
activation attenuates the severity of autoimmune diseases such
as type I diabetes mellitus and inﬂammatory bowel disease
[11,12], and therefore HVEM and its ligand are considered to be
therapeutic targets in those inﬂammatory diseases. Recently a link
between LIGHT/HVEM and obesity has been reported by Bassols
et al. [13,14]. Moreover our previous study has demonstrated that
soluble LIGHT promotes T cells/macrophages inﬁltration/activation
in vitro, and the LIGHT-induced inﬂammatory responses are
blunted by neutralizing antibody or disruption of HVEM [9], indi-
cating that LIGHT/HVEM interaction plays a role in adipose tissue
inﬂammation through HVEM interaction with LIGHT. However, it
remains unclear whether blockade of HVEM could protect obes-
ity-induced inﬂammation and pathologies in vivo.
In this study, we fed HVEM-deﬁcient mice a high-fat diet and
demonstrated that HVEM deﬁciency ameliorates not only adipose
tissue inﬂammatory responses but also glucose intolerance. HVEM
may be a novel target for treating obesity-induced inﬂammatory
responses and complications.
2. Materials and methods
See Supplementary material.lsevier B.V. All rights reserved.
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Data are presented as means ± S.E. Statistical analysis was per-
formed using ANOVA and Duncan’s multiple-range test. Differ-
ences were considered to be signiﬁcant at P < 0.05.
3. Results
3.1. Body weight change, food intake, and adiposity in HFD-fed HVEM-
deﬁcient mice
To see whether HVEM deﬁciency alters obesity-related pheno-
types, we fed HVEM-deﬁcient mice a HFD, and measured diet in-
take, body weight gain and adiposity. RT-PCR analysis displayed
that HVEM mRNA was absent in adipose tissue, liver, and spleen
of HVEM-deﬁcient mice (Fig. 1A). We observed a signiﬁcant reduc-
tion in body weight after 12 weeks in 45% HFD-fed HVEM-deﬁcient
mice and after 5 weeks in 60% HFD-fed HVEM-deﬁcient mice com-
pared with the HFD-fed wild type control mice (Fig. 1B), and no dif-
ference was observed in the lean mice fed a LFD (Fig. 1B). Gross
inspection of abdominal dissections revealed smaller masses of
adipose tissue in the HVEM-deﬁcient mice on a high-fat diet than
in the control obese mice (Fig. 1C). Adipose tissue weights in the
HFD-fed HVEM-deﬁcient mice were signiﬁcantly lower than those
in the HFD-fed wild type mice (Fig. 1D). Total diet intake of the
HFD-fed HVEM-deﬁcient mice was not signiﬁcantly different from
the HFD-fed wild type control (Fig. 1E). To see whether the reduced
body weight gain and adiposity observed in HFD-fed HVEM deﬁ-
cient mice was due to increased energy expenditure, we measuredFig. 1. Body weight change, food intake, and adiposity in HVEM-deﬁcient obese mice. HV
for 10 and 19 weeks, respectively. (A) HVEM mRNA in tissues was detected by RT-PCR.
epididymal; Re, renal; Me, mesenteric; Sc, subcutaneous) of wild type mice and HVEM-de
intake. (F) UCP-1 protein levels. UCP-1 protein in the brown adipose tissue of each mic
means ± S.E. ⁄P < 0.05, #P < 0.005, ##P < 0.001 compared to wild type obese mice.UCP-1 expression in brown adipose tissue, which plays a crucial
role in the control of energy expenditure. The levels of UCP-1 pro-
tein in brown adipose tissue were signiﬁcantly higher in the HVEM
deﬁcient obese mice than in the WT control mice (Fig. 1F), indicat-
ing that HVEM deﬁciency increases thermogenesis, thus increasing
energy expenditure. There was no phenotypic difference in fat
mass and diet intake between LFD-fed HVEM-deﬁcient lean mice
and LFD-fed wild type lean mice (Fig. 1D and E).
3.2. Adipose macrophages and T cells in HFD-fed HVEM-deﬁcient mice
To determine whether HVEM deﬁciency alters adipose tissue
inﬂammatory responses, we examined the increment of adipose
immune cell inﬁltration in obesity. Histochemical examination
showed that the adipocytes of the HFD-fed HVEM-deﬁcient mice
were smaller then those of the HFD-fed WT controls
(6463 ± 347 lm2 in the HVEM-deﬁcient mice vs. 7937 ± 670 lm2
in the WT mice), and the percentage of hypertrophic adipocytes
(P12 000 lm2) was signiﬁcantly lower in the HFD-fed HVEM-deﬁ-
cient mice than the HFD-fed WT mice (Fig. 2A). Moreover, the
numbers of cells inﬁltrated into adipose tissue were markedly re-
duced in the HFD-fed HVEM-deﬁcient mice compared with the
wild type obese controls (Fig. 2A). Flow cytometry revealed that to-
tal cell numbers in the SVF from adipose tissue also decreased
markedly (Fig. 2B), as did the numbers of macrophages (CD11b+/
F4/80+) and T cells (CD4+ or CD8+) (Fig. 2C and D). Moreover,
the HFD-fed HVEM-deﬁcient mice contained fewer activated T
cells (CD44+/CD62) (Fig. 2E), indicating that HVEM deﬁciency
reduces adipose tissue leukocytes recruitment and their activationEM-deﬁcient mice and wild type mice were fed 60% high-fat diet or 45% high-fat diet
(B) Total body weight gain. (C) Gross body shape. (D) Adipose tissue weights (Ep,
ﬁcient mice fed a low-fat diet (LFD) or a high-fat diet (HFD). (E) Amount of total diet
e was examined by Western blot analysis using the indicated antibodies. Data are
Fig. 2. Adipose macrophages and T cells in HFD-fed HVEM-deﬁcient mice. (A) Histochemistry of adipose tissue and adipocyte size. Arrows show inﬁltrated cells. Sections
obtained from the animals were stained with hematoxylin and eosin. Original magniﬁcation, 200 and 400. Data are means ± S.E. ⁄P < 0.05, #P < 0.005 compared to wild
type obese mice. Immune cells in the adipose stromal vascular fraction were analyzed. Stromal vascular cells were isolated from the epididymal adipose tissue of HFD-fed
HVEM-deﬁcient mice and HFD-fed wild type mice. (B) Stromal vascular fraction cells (C) Macrophages (D) T cells (E) Activated T cells. The isolated cells were labeled with
conjugated antibodies to CD11b, F4/80, CD4, CD8, CD44, CD62L and analyzed by ﬂow cytometry. The values are numbers of cells per gram epididymal adipose tissue shown in
fold decrease. Data are representative of three independent experiments.
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the leukocyte inﬁltration between LFD-fed HVEM-deﬁcient lean
mice and LFD-fed wild type lean mice (data not shown).
3.3. Cytokine levels in epididymal adipose tissue of HFD-fed HVEM-
deﬁcient mice
To examine whether HVEM deﬁciency affects inﬂammatory
cytokine proﬁles in adipose tissue, we measured TNFa, MCP-1
and IL-6 mRNA levels in epididymal adipose tissue. The levels of
cytokine gene expression were signiﬁcantly lower in the HFD-fed
HVEM-deﬁcient mice than in the HFD-fed wild type mice
(Fig. 3A), and this was conﬁrmed at the protein level (Fig. 3B). IL-
10 is an anti-inﬂammatory cytokine which is associated with insu-
lin sensitivity [15]. It has been shown that low IL-10 levels dispose
to the development of type 2 diabetes and metabolic syndrome
[16]. We tested whether HVEM deﬁciency affects the IL-10 mRNA
and protein levels in epididymal adipose tissue. As shown in Fig. 3Cand D, IL-10 was increased in the HFD-fed HVEM-deﬁcient mice
compared with HFD-fed wild type mice. No differences were ob-
served in the cytokine levels between LFD-fed HVEM-deﬁcient lean
mice and LFD-fed wild type lean mice (Fig. 3A and B).
3.4. HVEM deﬁciency reduces obesity-induced glucose intolerance and
insulin resistance
To see whether the attenuation of adipose tissue inﬂammation
in the HFD-fed HVEM-deﬁcient mice is associated with glucose tol-
erance, we measured fasting glucose levels and performed oral glu-
cose tolerance test. Fasting glucose and insulin levels in the 45%
HFD-fed HVEM-deﬁcient mice were slightly lower than in the
HFD-fed wild type mice (Fig. 4A), and the oral glucose tolerance
test demonstrated that the impairment of glucose tolerance was
less severe in the HFD-fed HVEM-deﬁcient mice than in the HFD-
fed wild type mice (Fig. 4B). The 45% HFD-fed HVEM-deﬁcient mice
had signiﬁcantly lower levels of plasma glucose than the wild type
Fig. 3. Levels of cytokines in the adipose tissue of HFD-fed HVEM-deﬁcient mice. Epididymal adipose tissue was isolated from HVEM-deﬁcient mice and wild type mice fed a
LFD or HFD, and total RNA was extracted. (A) Cytokine mRNA levels. (B) Cytokine protein levels (TNFa, MCP-1, and IL-6). Anti-inﬂammatory IL-10 (C) mRNA and (D) protein
levels. The expression of inﬂammatory genes (TNFa, MCP-1, and IL-6) and anti-inﬂammatory (IL-10) was measured by real time-PCR. The levels of proteins in the adipose
tissue homogenates were measured by ELISA and normalized with total protein content, which was determined using the BCA protein assay. Values are means ± S.E. of
animals (n = 4 or n = 5) for each group. ⁄P < 0.05, #P < 0.005, ##P < 0.001 compared to the HFD-fed wild-type mice.
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of glucose intolerance was also conﬁrmed in 60% HFD-fed HVEM-
deﬁcient mice at 90 min (Fig. 4B). Additionally, Western blot anal-
ysis revealed that insulin responsiveness assessed by phosphoryla-
tions of IRS-1 and/or Akt was greater in HFD-fed HVEM-deﬁcient
mice than HFD-fed wild type control (Fig. 4C), and moreover
expression levels of GLUT4 protein were also increased in the
HFD-fed HVEM-deﬁcient mice (Fig. 4D). These results indicate that
HVEM-deﬁciency attenuates HFD-induced glucose intolerance and
improved insulin sensitivity.
4. Discussion
Obesity-induced inﬂammation mimics chronic inﬂammatory
conditions accompanied by increased inﬂammatory cells such as
activated macrophages/T cells and mediators such as cytokines/
chemokines. In this study, we demonstrate that HVEM deﬁciency
reduces obesity-induced adipose tissue inﬂammatory responses
and glucose intolerance.
HVEM plays important roles in various inﬂammatory processes.
Studies have shown that dysregulation of HVEM and its ligand sys-
tem, which exaggerates T cell responses, can lead to chronic
inﬂammation [17,18]. Although we and others have suggested an
association between HVEM or LIGHT and obesity parameters in hu-
mans and mice [13,14], the pathogenic effects and underlying
mechanism of HVEM have not been fully clariﬁed. Generally, key
events in obesity-induced inﬂammatory processes are character-
ized by the localized recruitment of activated macrophage/T cellsubsets into adipose tissue and increased inﬂammatory cytokine/
chemokine release from these cells. We previously showed that
soluble LIGHT directly induced macrophage and T cells migration
in vitro [9], and the LIGHT-induced inﬂammatory actions were
blunted by blockade of HVEM [9]. In view of the in vitro observa-
tion, we hypothesized that disruption of HVEM protects obesity-
induced adipose tissue inﬂammatory responses in vivo. Using
HVEM-deﬁcient mice fed a high-fat diet, we for the ﬁrst time found
that HVEM deﬁciency markedly reduced the accumulation of mac-
rophages and activated CD4+ and/or CD8+ T cells in the adipose tis-
sue of HFD-fed mice. The ﬁndings not only verify our in vitro
ﬁndings, but also suggest that HVEM plays a crucial role in obes-
ity-induced inﬁltration of T cells/macrophages into adipose tissue.
It has been shown that the interaction between HVEM and
LIGHT provides a pro-inﬂammatory signal to T cells or macro-
phages to produce inﬂammatory cytokines [17–19]. Previously,
our in vitro study has demonstrated that blocking of HVEM inhibits
the activation of macrophages stimulated by soluble LIGHT to pro-
duce inﬂammatory cytokines [14]. Thus we thought that HVEM
deﬁciency may reduce the release of inﬂammatory cytokines by
adipose tissue-derived soluble LIGHT, which increases in obese
condition. Indeed, we found that levels of inﬂammatory cytokine/
chemokine such as TNFa, IL-6, and MCP-1 are lower in the adipose
tissue of HFD-fed HVEM-deﬁcient mice. This notion is also sup-
ported by the evidence that HVEM-deﬁcient mice have reduced
numbers of activated CD4+ and CD8+ T cells in their adipose tissue.
In addition, it should be noted that adipocytes constitutively ex-
press HVEM [13] and activation of HVEM by LIGHT enhances the
Fig. 4. HVEM deﬁciency ameliorates obesity-induced glucose intolerance in obese mice fed a high-fat diet. (A) Fasting glucose and insulin levels (B) Oral glucose tolerance
test. Animals were fed a high fat diet 45% HFD (8 weeks, n = 12, male) for 14 weeks. Or, animals were fed 60% HFD (8 weeks, n = 4, male) for 7 weeks. Mice fed a high-fat diet
were fasted 12 h before receiving oral administration of a 20% glucose solution at a dose of 2 g/kg, and blood samples were taken at the indicated times. Levels of glucose were
measured with an enzymatic assay kit. (C and D) Insulin responses. After fasting 5 h, mice were stimulated with or without insulin for 4 min. Expression of p-Akt, total Akt, p-
IRS-1, total IRS-1 and GLUT4 proteins in the skeletal muscle of each mice was examined by Western blot analysis using the indicated antibodies. Values are means ± S.E.
⁄P < 0.05, #P < 0.005 compared to the HFD-fed wild type mice.
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HVEM deﬁciency blunts the HVEM-mediated inﬂammatory cross-
talk between adipose cells and T cells/macrophages in obesity,
which may be favorable for protecting adipose tissue inﬂamma-
tion. Given the role of T cells/macrophages in vicious cycle of adi-
pose tissue inﬂammation, the ﬁndings indicate that HVEM could be
a valid target to disrupt a pathogenic loop in the recruitment of T
cells and macrophages and their activation, which are crucial for
adipose tissue inﬂammation in obesity condition.
Obese adipose tissue T cells and macrophages participate in not
only for promoting adipose tissue inﬂammation but also insulin
resistance [4]. Obesity-induced chronic activation of pro-inﬂam-
matory signaling pathways in the adipose immune cells results
in elevated levels of TNFa, IL-6, and MCP-1, which inhibit insulin
signaling [3–5]. It has been shown that depletion of CD8+ T cells
lower macrophage inﬁltration and adipose tissue inﬂammation
and ameliorates systemic insulin resistance [20], while reduction
of CD4+ Th1 cells suppresses insulin resistance [5]. We found that
HFD-induced glucose intolerance and/or insulin sensitivity esti-mated by phosphorylations of IRS-1 and Akt were signiﬁcantly
attenuated in HFD-fed HVEM-deﬁcient mice. This indicates that
HVEM deﬁciency reduced adipose tissue inﬂammation through de-
creased inﬂammatory CD4+ and/or CD8+ T cells and cytokines,
which in turn ameliorates the HFD-induced pathological processes.
Additionally, given that IL-10 elicits insulin-sensitizing activity and
protects IL-6 and TNFa-induced cellular insulin resistance [21,22],
the attenuation of inﬂammation observed in the HFD-fed HVEM-
deﬁcient mice may at least in part be attributed to the increased
IL-10 in the adipose tissue.
HVEM not only transmits inﬂammatory signals which activate T
cells through the interaction with LIGHT, but also induces anti-
inﬂammatory signals by engaging coinhibitory receptor BTLA (B
and T lymphocyte attenuator) and/or CD160 which inhibits T cell
proliferation [23]. We previously observed that levels of HVEM
and LIGHT mRNA were signiﬁcantly increased in obese mice com-
pared with lean control [9], whereas BTLA expression was mark-
edly reduced [14]. With respect to this, it is seemingly that
LIGHT-mediated inﬂammatory signals may be in favor of obesity
2290 H.-J. Kim et al. / FEBS Letters 585 (2011) 2285–2290condition, and this may be disrupted in HFD-fed HVEM-deﬁcient
mice, leading to the improvement of obesity-related inﬂammation
and complications.
In conclusion, we have for the ﬁrst time demonstrated that
HVEM deﬁciency reduces adipose tissue inﬂammatory responses
as assessed by the decrease in inﬁltration of T cells/macrophages
and inﬂammatory cytokine levels, and thus counteracts the glu-
cose intolerance in mice fed a high-fat diet. HVEM may be a novel
target for reducing obesity-induced inﬂammatory responses and
complications.
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